Pharmabiz25m
Cellogen Therapeutics gets DCGI nod to develop indigenous Bi-Specific 3rd Generation CAR T cells for cancer
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
Pharmabiz40m
Oncorena receives US FDA approval to initiate studies in US
Oncorena, a Swedish pharma company, announced that the US FDA has approved the company’s IND application to initiate the phase I/II study Oncorella-1: A phase 1/2, open label, single arm study on ...
Pharmabiz50m
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset: Our Bureau, Bengaluru Wednesday, March ...
Pharmabiz59m
USV launches empagliflozin and its combinations for diabetes care in India
USV launches empagliflozin and its combinations for diabetes care in India: Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:40 Hrs [IST] USV, an Indian multinational healthcar ...